APA (7th ed.) Citation

JL, V., AM, D., R, K., M, G., CJ, K., NJ, L., . . . TM, S. (2026). Genomic risk model to implement precision prostate cancer screening in clinical care: The ProGRESS study. Nature cancer, 7(2), 352. https://doi.org/10.1038/s43018-025-01103-0

Chicago Style (17th ed.) Citation

JL, Vassy, et al. "Genomic Risk Model to Implement Precision Prostate Cancer Screening in Clinical Care: The ProGRESS Study." Nature Cancer 7, no. 2 (2026): 352. https://doi.org/10.1038/s43018-025-01103-0.

MLA (9th ed.) Citation

JL, Vassy, et al. "Genomic Risk Model to Implement Precision Prostate Cancer Screening in Clinical Care: The ProGRESS Study." Nature Cancer, vol. 7, no. 2, 2026, p. 352, https://doi.org/10.1038/s43018-025-01103-0.